Insider trades

Jan Pinkas, Chief Officer of Crescent Biopharma CBIO, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $23.2K. The latest trade was on 06/22.

Jan Pinkas

Chief Scientific Officer
First filing
25/07/16
Trades
5 trades
Buys / sales
0 / 1
12-month net buying
−$23.2K
Last trade
06/22

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/2206/231,288 sh$17.99$23,171.12−5.5%